- Home
- ILPT vs BWAY Comparison
ILPT vs BWAY Comparison
Compare ILPT & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILPT
- BWAY
- Stock Information
- Founded
- ILPT 2017
- BWAY 2003
- Country
- ILPT United States
- BWAY Israel
- Employees
- ILPT N/A
- BWAY N/A
- Industry
- ILPT Real Estate Investment Trusts
- BWAY Medical/Dental Instruments
- Sector
- ILPT Real Estate
- BWAY Health Care
- Exchange
- ILPT Nasdaq
- BWAY Nasdaq
- Market Cap
- ILPT 174.6M
- BWAY 207.4M
- IPO Year
- ILPT 2018
- BWAY 2019
- Fundamental
- Price
- ILPT $3.15
- BWAY $8.76
- Analyst Decision
- ILPT Buy
- BWAY Strong Buy
- Analyst Count
- ILPT 2
- BWAY 3
- Target Price
- ILPT $10.00
- BWAY $13.17
- AVG Volume (30 Days)
- ILPT 315.1K
- BWAY 24.4K
- Earning Date
- ILPT 04-29-2025
- BWAY 05-13-2025
- Dividend Yield
- ILPT 1.26%
- BWAY N/A
- EPS Growth
- ILPT N/A
- BWAY N/A
- EPS
- ILPT N/A
- BWAY 0.06
- Revenue
- ILPT $441,992,000.00
- BWAY $41,016,000.00
- Revenue This Year
- ILPT $8.07
- BWAY $351.53
- Revenue Next Year
- ILPT N/A
- BWAY $21.84
- P/E Ratio
- ILPT N/A
- BWAY $57.37
- Revenue Growth
- ILPT 0.61
- BWAY 29.04
- 52 Week Low
- ILPT $2.45
- BWAY $5.13
- 52 Week High
- ILPT $5.45
- BWAY $11.79
- Technical
- Relative Strength Index (RSI)
- ILPT 58.47
- BWAY 47.80
- Support Level
- ILPT $2.77
- BWAY $8.61
- Resistance Level
- ILPT $3.15
- BWAY $9.09
- Average True Range (ATR)
- ILPT 0.17
- BWAY 0.38
- MACD
- ILPT 0.08
- BWAY 0.05
- Stochastic Oscillator
- ILPT 93.01
- BWAY 58.73
About ILPT Industrial Logistics Properties Trust of Beneficial Interest
Industrial Logistics Properties Trust is a real estate investment trust. It owns and leases industrial and logistics properties throughout the United States. The company's investment portfolio includes industrial lands in Hawaii and industrial and logistics properties in other states. Rental revenue is earned from Hawaii Properties and Mainland Properties.
About BWAY BrainsWay Ltd.
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.